Results has advised Agile MV on its acquisition by Resonetics

  • Service: M&A
  • Sector: Healthcare
  • Sub Sector: CROs & CMOs
  • Engagement Type: Sell Side
Jun 2022
has been acquired by
A company backed by GTCR and The Carlyle Group

Results is pleased to announce that it has acted as the exclusive financial advisor to Agile MV (the “Company”), a leading contract development and manufacturing organization focused on medical devices, on its sale to Resonetics LLC, a portfolio company of GTCR and The Carlyle Group.

Agile MV, based in Montreal, Quebec, specializes in the design and manufacture of minimally invasive medical devices, with particular expertise in electrophysiology and interventional cardiology. It counts among its clients some of the largest medical device companies in the world as well as early-stage companies seeking to develop new innovations in the sector. Since starting its operation in 2014, the Company has assisted its clients in developing products that have treated over a million patients around the world, and has grown to over 100 full-time employees, including engineers, technicians, and product builders.

The acquisition of Agile MV will enable Resonetics, a world leader in micro manufacturing, to continue its expansion of expertise across the spectrum of minimally invasive medical devices and assist in its rapid prototyping and development initiatives.

The combination of US-based Resonetics and Canadian-based Agile MV is another example of Results’ expertise in brokering cross-border transactions.

Pierre-Georges Roy and Jason Foss led the transaction with the close support of Matt Duff and Leo Bucksbaum in New York and Murelli Sooriyakumar in London.

We were very pleased with the advice and assistance the Results team provided in guiding us through this process. After founding the business and running it for over eight years, we were looking for a strong partner to help us move into the next stage of growth and expansion. That’s exactly what Results found for us with Resonetics. We could not be happier with the outcome, and are excited to work with our new colleagues to continue helping our clients bring groundbreaking medical devices to market.

Jean-Luc Pageard

President and Co-Founder of Agile MV

Sector Related Deals

Jul 2022
has divested its API site in Rhode Island, USA, to
Jun 2022
A Kester Capital-backed company
has received investment from
Mar 2022
has divested its Ringaskiddy, Ireland, manufacturing facility
Mar 2022
has divested its Boucherville, Canada manufacturing facility
Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company
Jun 2021
has acquired a drug product manufacturing facility from
May 2021
has been acquired by
a Behrman Capital-backed company
Feb 2021
has been acquired by